Historical salary details - Dr. Clay B. Siegall,PhD, Chairman of the Board, Tourmaline Bio Inc
Dr. Clay B. Siegall,PhD is the Chairman of the Board of Tourmaline Bio Inc. They also hold 2 other positions in Shattuck Labs Inc and Immunome Inc.
Dr. Clay B. Siegall,Phd
Chairman of the Board
$ 230.1 K
Gross Remuneration
-
Current Company
Tourmaline Bio Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Tourmaline Bio Inc | Chairman of the Board | 230.1 K | -16.3 % |
| 2024 | Shattuck Labs Inc | Director | - | - |
| 2024 | Immunome Inc | Chief Executive Officer, President and Chairman of | - | - |
| 2023 | Tourmaline Bio Inc | Chairman of the Board | 274.8 K | - |
| 2023 | Immunome Inc | Chief Executive Officer, President and Chairman of | - | - |
| 2022 | Nurix Therapeutics Inc | - | 22.5 K | -96.5 % |
| 2022 | Nurix Therapeutics Inc | Independent Director | - | - |
| 2021 | Nurix Therapeutics Inc | Independent Director | 635.0 K | - |
| 2021 | Ultragenyx Pharmaceutical Inc. | - | 30 K | -93.0 % |
| 2021 | Ultragenyx Pharmaceutical Inc. | Independent Director | - | - |
| 2020 | Ultragenyx Pharmaceutical Inc. | Independent Director | 426.1 K | 6.9 % |
| 2019 | Ultragenyx Pharmaceutical Inc. | Independent Director | 398.4 K | -25.4 % |
| 2018 | Ultragenyx Pharmaceutical Inc. | Independent Director | 534.2 K | 62.1 % |
| 2017 | Ultragenyx Pharmaceutical Inc. | Independent Director | 329.6 K | 4.9 % |
| 2016 | Ultragenyx Pharmaceutical Inc. | Independent Director | 314.1 K | -30.2 % |
| 2016 | Synlogic Inc | Independent Director | - | - |
| 2015 | Ultragenyx Pharmaceutical Inc. | Independent Director | 450.2 K | 0.9 % |
| 2015 | Synlogic Inc | Independent Director | 166.9 K | 54.8 % |
| 2014 | Ultragenyx Pharmaceutical Inc. | Independent Director | 446.1 K | - |
| 2014 | Synlogic Inc | Independent Director | 107.8 K | - |
| 2013 | Ultragenyx Pharmaceutical Inc. | Independent Director | - | - |